{"id":27849,"date":"2025-10-22T16:22:17","date_gmt":"2025-10-22T23:22:17","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27849"},"modified":"2026-04-23T13:55:38","modified_gmt":"2026-04-23T20:55:38","slug":"ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/","title":{"rendered":"Ojjaara: Una nueva terapia oral para tratar un c\u00e1ncer de sangre poco com\u00fan"},"content":{"rendered":"<p>Ojjaara es un medicamento de prescripci\u00f3n oral que se usa para tratar ciertas formas de mielofibrosis (un tipo de c\u00e1ncer de m\u00e9dula \u00f3sea) en adultos con anemia.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-bcd2f3778ab7dba8a5aeb5752ed96f5d\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Ojjaara_Introduction_and_Uses\" >Introducci\u00f3n y usos del Ojjaara<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Ojjaara_Mechanism_of_Action\" >Mecanismo de acci\u00f3n del Ojjaara&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Ojjaara_Dosage\" >Dosis de Ojjaara<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Ojjaara_Side_Effects\" >Efectos secundarios del Ojjaara<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Common_side_effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Severe_side_effects\" >Efectos secundarios graves<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Heart_attack_or_stroke\" >Ataque card\u00edaco o accidente cerebrovascular<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Blood_clots\" >co\u00e1gulos de sangre<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#New_cancers\" >Nuevos c\u00e1nceres<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Use_in_Pregnancy\" >Uso durante el embarazo&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Use_in_Lactation\" >Uso en la lactancia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Before_Taking_Ojjaara\" >Antes de tomar Ojjaara<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Missed_Dose_and_Overdose\" >Dosis olvidada y sobredosis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Proper_Use_Storage_and_Disposal\" >Uso, almacenamiento y eliminaci\u00f3n adecuados<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#Ojjaara_Cost\" >Costo del Ojjaara<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ojjaara_Introduction_and_Uses\"><\/span>Introducci\u00f3n y usos del Ojjaara<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ojjaara es un producto de marca. Contiene el principio activo momelotinib, que pertenece a la clase de f\u00e1rmacos inhibidores de la cinasa Janus (JAK). Actualmente no existen versiones gen\u00e9ricas de este medicamento.&nbsp;<\/p>\n\n\n\n<p>Ojjaara no es quimioterapia, sino una terapia dirigida que reduce la actividad del sistema inmunol\u00f3gico para el tratamiento del c\u00e1ncer.&nbsp;<\/p>\n\n\n\n<p>En 2023, la FDA de EE. UU. aprob\u00f3 este medicamento para tratar ciertas formas de <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/symptoms-causes\/syc-20355057\">mielofibrosis<\/a> En adultos con anemia. La mielofibrosis es un c\u00e1ncer poco com\u00fan que provoca la formaci\u00f3n de tejido cicatricial en la m\u00e9dula \u00f3sea. Como resultado, la m\u00e9dula \u00f3sea no produce suficientes c\u00e9lulas sangu\u00edneas sanas, lo que provoca:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dificultad para respirar y cansancio<\/li>\n\n\n\n<li>F\u00e1cil aparici\u00f3n de hematomas o sangrado&nbsp;<\/li>\n\n\n\n<li>Infecciones recurrentes&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>El h\u00edgado o el bazo tambi\u00e9n pueden agrandarse.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ojjaara_Mechanism_of_Action\"><\/span>Mecanismo de acci\u00f3n del Ojjaara&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Ojjaara es un inhibidor de la cinasa Janus (JAK). Las c\u00e9lulas de la m\u00e9dula \u00f3sea contienen prote\u00ednas (JAK) que se hiperactivan cuando se padece mielofibrosis. El Ojjaara bloquea la acci\u00f3n de estas prote\u00ednas. Adem\u00e1s, el Ojjaara bloquea otra prote\u00edna en las c\u00e9lulas hep\u00e1ticas, lo que aumenta el nivel de gl\u00f3bulos rojos sanos.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ojjaara_Dosage\"><\/span>Dosis de Ojjaara<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara.jpg\" alt=\"A senior woman taking a tablet of Ojjaara\" class=\"wp-image-27852\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/patient-ojjaara-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Ojjaara viene en tabletas de 100 mg, 150 mg y 200 mg que se toman por v\u00eda oral.&nbsp;<\/p>\n\n\n\n<p>La dosis recomendada es de 200 mg por v\u00eda oral una vez al d\u00eda. Su profesional de la salud podr\u00eda recetarle una dosis menor, 150 mg por v\u00eda oral una vez al d\u00eda, si tiene problemas hep\u00e1ticos graves.&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p>Antes y durante el tratamiento con este medicamento, su profesional de la salud le controlar\u00e1 el hemograma y la funci\u00f3n hep\u00e1tica. Adem\u00e1s, le solicitar\u00e1n pruebas para determinar si tiene hepatitis B activa antes de comenzar a tomar este medicamento.&nbsp;<\/p>\n\n\n\n<p>El tratamiento con Ojjaara es a largo plazo y probablemente continuar\u00e1 mientras sea seguro y eficaz para usted. Sin embargo, si experimenta efectos secundarios graves o si el medicamento deja de surtir efecto, su profesional de la salud podr\u00eda solicitarle que lo suspenda temporal o permanentemente.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ojjaara_Side_Effects\"><\/span>Efectos secundarios del Ojjaara<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_side_effects\"><\/span>Efectos secundarios comunes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Recuento bajo de plaquetas<\/li>\n\n\n\n<li>Sangr\u00eda<\/li>\n\n\n\n<li>Infecci\u00f3n bacteriana<\/li>\n\n\n\n<li>Cansancio<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Dolor en la espalda, la pierna o el brazo.&nbsp;<\/li>\n\n\n\n<li>Erupci\u00f3n&nbsp;<\/li>\n\n\n\n<li>Picor&nbsp;<\/li>\n\n\n\n<li>Visi\u00f3n borrosa&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>Hable con su proveedor de atenci\u00f3n m\u00e9dica o farmac\u00e9utico si alg\u00fan efecto secundario empeora o no mejora con el tiempo.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-67248c221b6216d501e6e74eee6b3e4b\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Severe_side_effects\"><\/span>Efectos secundarios graves<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Llame a su proveedor de atenci\u00f3n m\u00e9dica de inmediato o busque atenci\u00f3n de emergencia si tiene signos y s\u00edntomas de:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Infecciones<\/strong>, como fiebre, escalofr\u00edos, tos, dificultad para respirar, diarrea, v\u00f3mitos, dolor o sensaci\u00f3n de ardor al orinar.<\/li>\n\n\n\n<li><strong>recuento bajo de plaquetas<\/strong>, como sangrado o hematomas inexplicables o heces alquitranadas<\/li>\n\n\n\n<li><strong>Problemas de h\u00edgado<\/strong>, como piel u ojos amarillentos, o dolor en la regi\u00f3n superior derecha del est\u00f3mago&nbsp;<\/li>\n\n\n\n<li><strong>Reacciones cut\u00e1neas graves<\/strong>, como s\u00edntomas parecidos a la gripe, erupciones cut\u00e1neas graves, descamaci\u00f3n de la piel, ampollas en los labios, los ojos o la boca.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Heart_attack_or_stroke\"><\/span>Ataque card\u00edaco o accidente cerebrovascular<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Aunque no se ha informado espec\u00edficamente en personas que toman Ojjaara, se han reportado ataques card\u00edacos y accidentes cerebrovasculares en personas que toman un inhibidor de JAK diferente. El riesgo puede ser mayor entre fumadores actuales o exfumadores. Busque atenci\u00f3n m\u00e9dica de emergencia si experimenta cualquier signo o s\u00edntoma de un ataque card\u00edaco o un accidente cerebrovascular, como:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Malestar en el pecho<\/li>\n\n\n\n<li>Sensaci\u00f3n intensa de opresi\u00f3n, dolor, presi\u00f3n o pesadez en el pecho, la garganta, el cuello o la mand\u00edbula.<\/li>\n\n\n\n<li>Dolor o malestar en los brazos, la espalda, el cuello, la mand\u00edbula o el est\u00f3mago.<\/li>\n\n\n\n<li>Dificultad para respirar con o sin molestias en el pecho<\/li>\n\n\n\n<li>N\u00e1useas o v\u00f3mitos<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Debilidad en una parte o en un lado del cuerpo<\/li>\n\n\n\n<li>Habla arrastrada<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Blood_clots\"><\/span>co\u00e1gulos de sangre<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Se han presentado co\u00e1gulos de sangre en brazos o piernas (trombosis venosa profunda o TVP) o en las arterias o pulmones (embolia pulmonar o EP) en personas que toman inhibidores de JAK como Ojjaara. Acuda a urgencias de inmediato si experimenta:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hinchaz\u00f3n, dolor o sensibilidad en una o ambas piernas<\/li>\n\n\n\n<li>Dolor repentino e inexplicable en el pecho<\/li>\n\n\n\n<li>Dificultad para respirar<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"New_cancers\"><\/span>Nuevos c\u00e1nceres<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Tomar inhibidores de JAK puede aumentar el riesgo de desarrollar nuevos c\u00e1nceres. El riesgo puede ser mayor entre fumadores actuales o exfumadores. Consulte con su profesional de la salud sobre el riesgo de desarrollar nuevos c\u00e1nceres mientras toma este medicamento.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Use_in_Pregnancy\"><\/span>Uso durante el embarazo&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Estudios en animales sugieren que este medicamento podr\u00eda ser perjudicial para el feto. Evite quedar embarazada durante el tratamiento y durante siete d\u00edas despu\u00e9s de la \u00faltima dosis. Informe a su profesional de la salud inmediatamente si queda embarazada durante el tratamiento.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Use_in_Lactation\"><\/span>Uso en la lactancia<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Estudios en animales sugieren que el Ojjaara puede pasar a la leche materna, lo que puede transmitirse al beb\u00e9. Evite la lactancia materna durante el tratamiento y durante los 7 d\u00edas posteriores a la \u00faltima dosis.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-b4f2beba9c9d204a4233b20076333c81\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Before_Taking_Ojjaara\"><\/span>Antes de tomar Ojjaara<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de tomar su primera dosis, informe a su proveedor de atenci\u00f3n m\u00e9dica si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene una infecci\u00f3n<\/li>\n\n\n\n<li>Tiene o ha tenido hepatitis B<\/li>\n\n\n\n<li>Tiene o ha tenido problemas de h\u00edgado.<\/li>\n\n\n\n<li>Ha tenido un ataque card\u00edaco, otros problemas card\u00edacos o un derrame cerebral.<\/li>\n\n\n\n<li>Tiene o ha tenido un co\u00e1gulo de sangre<\/li>\n\n\n\n<li>Fuma o fum\u00f3 en el pasado<\/li>\n\n\n\n<li>Tiene o ha tenido otros tipos de c\u00e1ncer.<\/li>\n\n\n\n<li>\u00bfEst\u00e1 embarazada o planea quedar embarazada?<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Missed_Dose_and_Overdose\"><\/span>Dosis olvidada y sobredosis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Omita la dosis olvidada y contin\u00fae con la pauta de dosificaci\u00f3n recomendada. Nunca tome una dosis doble para compensar la dosis olvidada.&nbsp;<\/p>\n\n\n\n<p>Si cree que ha sufrido una sobredosis de Ojjaara, comun\u00edquese con la l\u00ednea de ayuda contra intoxicaciones (1-800-222-1222) o busque ayuda m\u00e9dica acudiendo a una sala de emergencias de inmediato.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Proper_Use_Storage_and_Disposal\"><\/span>Uso, almacenamiento y eliminaci\u00f3n adecuados<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Antes de usar este medicamento, lea atentamente las instrucciones de la etiqueta de la receta. Tome sus dosis exactamente como se indica.&nbsp;<\/li>\n\n\n\n<li>Si tiene alguna duda, consulte a su m\u00e9dico o farmac\u00e9utico.&nbsp;<\/li>\n\n\n\n<li>Trague la tableta entera; evite triturarla, masticarla o romperla.&nbsp;<\/li>\n\n\n\n<li>Puede tomar este medicamento con o sin alimentos.<\/li>\n\n\n\n<li>Nunca deje de tomar este o cualquier otro medicamento sin consultar antes con su proveedor de atenci\u00f3n m\u00e9dica.<\/li>\n\n\n\n<li>Conserve este medicamento a temperaturas entre 20 \u00b0C y 25 \u00b0C (68 \u00b0F y 77 \u00b0F). Se puede permitir su conservaci\u00f3n entre 15 \u00b0C y 30 \u00b0C (59 \u00b0F y 86 \u00b0F) durante un breve periodo.<\/li>\n\n\n\n<li>Conserve Ojjaara en el frasco original, que contiene un sobre desecante que protege las tabletas de la humedad. Nunca deseche el desecante.<\/li>\n\n\n\n<li>Vuelva a colocar la tapa firmemente cada vez que tome las tabletas recomendadas.<\/li>\n\n\n\n<li>Deseche los medicamentos no utilizados o caducados siguiendo las normativas locales. Haga clic aqu\u00ed. <a href=\"https:\/\/www.fda.gov\/drugs\/safe-disposal-medicines\/disposal-unused-medicines-what-you-should-know\">AQU\u00cd<\/a> para aprender c\u00f3mo desechar medicamentos innecesarios o vencidos.&nbsp;<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ojjaara_Cost\"><\/span>Costo del Ojjaara<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El costo puede variar seg\u00fan su seguro m\u00e9dico, ubicaci\u00f3n y farmacia. Consulte con su aseguradora si su plan cubre este medicamento o si necesita autorizaci\u00f3n previa.&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/www.gsk.com\/en-gb\/\">GSK (GlaxoSmithKline)<\/a>, el fabricante de Ojjaara, puede brindar asistencia financiera y soporte de reembolso si usted es elegible.\u00a0<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a> si est\u00e1 interesado en explorar finanzas y <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ojjaara-copay-assistance\/\">Asistencia para el copago del programa Ojjaara<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Ojjaara es un medicamento oral con receta que se utiliza para tratar ciertas formas de mielofibrosis (un tipo de c\u00e1ncer de m\u00e9dula \u00f3sea) en adultos con anemia. Ojjaara es un producto de marca. Contiene el principio activo momelotinib, que pertenece a la clase de f\u00e1rmacos inhibidores de la cinasa Janus (JAK).<\/p>","protected":false},"author":26,"featured_media":27850,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[32],"class_list":["post-27849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer<\/title>\n<meta name=\"description\" content=\"Learn about Ojjaara and how it treats myelofibrosis. Topics include mechanism of action, dosage, side effects, cost, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer\" \/>\n<meta property=\"og:description\" content=\"Learn about Ojjaara and how it treats myelofibrosis. Topics include mechanism of action, dosage, side effects, cost, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-22T23:22:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T20:55:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer\",\"datePublished\":\"2025-10-22T23:22:17+00:00\",\"dateModified\":\"2026-04-23T20:55:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/\"},\"wordCount\":1093,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cancer-patient-doctor.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/\",\"name\":\"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cancer-patient-doctor.jpg\",\"datePublished\":\"2025-10-22T23:22:17+00:00\",\"dateModified\":\"2026-04-23T20:55:38+00:00\",\"description\":\"Learn about Ojjaara and how it treats myelofibrosis. Topics include mechanism of action, dosage, side effects, cost, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cancer-patient-doctor.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cancer-patient-doctor.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A cancer patient discussing Ojjaara with a doctor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ojjaara: Una nueva terapia oral para tratar un c\u00e1ncer de sangre poco com\u00fan","description":"Aprenda sobre el Ojjaara y c\u00f3mo trata la mielofibrosis. Los temas incluyen el mecanismo de acci\u00f3n, la dosis, los efectos secundarios, el costo y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/","og_locale":"es_MX","og_type":"article","og_title":"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer","og_description":"Learn about Ojjaara and how it treats myelofibrosis. Topics include mechanism of action, dosage, side effects, cost, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-10-22T23:22:17+00:00","article_modified_time":"2026-04-23T20:55:38+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer","datePublished":"2025-10-22T23:22:17+00:00","dateModified":"2026-04-23T20:55:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/"},"wordCount":1093,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/","url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/","name":"Ojjaara: Una nueva terapia oral para tratar un c\u00e1ncer de sangre poco com\u00fan","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg","datePublished":"2025-10-22T23:22:17+00:00","dateModified":"2026-04-23T20:55:38+00:00","description":"Aprenda sobre el Ojjaara y c\u00f3mo trata la mielofibrosis. Los temas incluyen el mecanismo de acci\u00f3n, la dosis, los efectos secundarios, el costo y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg","width":1280,"height":853,"caption":"A cancer patient discussing Ojjaara with a doctor"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ojjaara-a-new-oral-therapy-to-treat-rare-blood-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Dr. Robert Hakim, Doctor en Farmacia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"El Dr. Robert Chad Hakim, PharmD, naci\u00f3 y creci\u00f3 en Northridge, California. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Wisconsin-Madison. Lo m\u00e1s gratificante de su trabajo es tomar la iniciativa para impulsar programas cl\u00ednicos que maximicen el impacto en la atenci\u00f3n al paciente. Cuenta con una certificaci\u00f3n del consejo en cuidados cr\u00edticos (BCCCP) y sus \u00e1reas de especializaci\u00f3n son cuidados cr\u00edticos, informaci\u00f3n sobre medicamentos, medicina general y cardiolog\u00eda. En su tiempo libre, disfruta viajando.\u00a0","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"Ojjaara is an oral prescription medicine used to treat certain forms of myelofibrosis (a type of bone marrow cancer) in adults with anemia.\u00a0Ojjaara is a brand-name product. It contains the active ingredient momelotinib, which belongs to the Janus kinase (JAK) inhibitor drug class.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/10\/cancer-patient-doctor.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Ojjaara is an oral prescription medicine used to treat certain forms of myelofibrosis (a type of bone marrow cancer) in adults with anemia.\u00a0Ojjaara is a brand-name product. It contains the active ingredient momelotinib, which belongs to the Janus kinase (JAK) inhibitor drug class.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27849"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27849\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27850"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27849"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}